Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Treasury Shares (2016 - 2026)

Champions Oncology (CSBR) has 11 years of Treasury Shares data on record, last reported at $708000.0 in Q4 2025.

  • For Q4 2025, Treasury Shares changed 0.0% year-over-year to $708000.0; the TTM value through Oct 2025 reached $708000.0, changed 0.0%, while the annual FY2025 figure was $708000.0, 0.0% changed from the prior year.
  • Treasury Shares reached $120300.0 in Q4 2025 per CSBR's latest filing, roughly flat from $120333.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $120333.0 in Q1 2024 and bottomed at $4896.0 in Q4 2023.
  • Average Treasury Shares over 3 years is $99762.4, with a median of $120333.0 recorded in 2024.
  • The widest YoY moves for Treasury Shares: up 856.76% in 2024, down 0.0% in 2024.
  • A 3-year view of Treasury Shares shows it stood at $708000.0 in 2023, then changed by 0.0% to $708000.0 in 2024, then changed by 0.0% to $708000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Treasury Shares were $708000.0 in Q4 2025, $708000.0 in Q3 2025, and $708000.0 in Q2 2025.